Real world use of tirzepatide in the treatment of type 2 diabetes in an Arab population.

Adam J BuckleySara SulimanMatthew AllumNagi MohammedNader LessanCarel W le RouxMohamed Suliman

Published in: Diabetes, obesity & metabolism (2024)

In real-world use, tirzepatide significantly reduced HbA1c levels and weight and was well tolerated. Previous GLP-RA use was associated with significantly lesser HbA1c and weight reduction, and previous metabolic bariatric surgery was associated with greater weight loss.

Keyphrases

weight loss
bariatric surgery
roux en y gastric bypass
obese patients
gastric bypass
weight gain
rheumatoid arthritis
physical activity
type diabetes
disease activity
systemic lupus erythematosus
interstitial lung disease
adipose tissue
smoking cessation
body weight
skeletal muscle
insulin resistance